Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
28,567,042
-
Shares change
-
-1,878,588
-
Total reported value, excl. options
-
$202,093,852
-
Value change
-
-$12,310,362
-
Put/Call ratio
-
52%
-
Number of buys
-
57
-
Number of sells
-
-50
-
Price
-
$7.02
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2016
141 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2016.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,567,042 shares
of 80,437,135 outstanding shares and own 35.51% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,598,539 shares), VANGUARD GROUP INC (2,329,802 shares), Camber Capital Management LLC (1,500,000 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,433,975 shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (1,400,643 shares), PICTET ASSET MANAGEMENT LTD (1,329,215 shares), BlackRock Fund Advisors (1,299,528 shares), BB BIOTECH AG (1,182,912 shares), FMR LLC (1,136,211 shares), and BlackRock Institutional Trust Company, N.A. (812,757 shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.